REQUEST A DEMO
Total
USD $0.00
Search more companies

Translab (M) Sdn.Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Translab (M) Sdn.Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Dealing in medical, dental, scientific, laboratory, industrial, educational, safety, law enforcement, security and digital products, services, training, testing and consultancy.

Headquarters
18 Jalan Pjs 11/16, Bandar Sunway
Petaling Jaya; Selangor; Postal Code: 46150

Contact Details: Purchase the Translab (M) Sdn.Bhd. report to view the information.

Website: http://www.translab.my

Basic Information
Total Employees:
Purchase the Translab (M) Sdn.Bhd. report to view the information.
Outstanding Shares:
Purchase the Translab (M) Sdn.Bhd. report to view the information.
Registered Capital:
Purchase the Translab (M) Sdn.Bhd. report to view the information.
Financial Auditors:
Purchase the Translab (M) Sdn.Bhd. report to view the information.
Incorporation Date:
February 13, 1984
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
30%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Translab (M) Sdn.Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
258.74%
Total operating revenue
258.74%
Operating profit (EBIT)
1504.36%
EBITDA
1215.27%
Net Profit (Loss) for the Period
1497.12%
Total assets
133.09%
Total equity
111.51%
Operating Profit Margin (ROS)
11.62%
Net Profit Margin
8.69%
Return on Equity (ROE)
73.54%
Debt to Equity Ratio
-43.16%
Quick Ratio
-0%
Cash Ratio
0.66%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?